Abstract:The study was aimed to compare the safety of hematopoietic stem cell mobilization and collection in related donors providing bone marrow and peripheral blood stem cells and in unrelated donors providing peripheral blood stem cells only. 100 related donors from September 2005 to August 2006 at Institute of Hematology & People Hospital, Peking University, and 71 unrelated donors from November 2003 to December 2007 in Data Bank of Chinese Hematopoietic Stem Cell Donor Beijing Management Center, were observed in process of bone marrow and peripheral blood stem cell mobilization, collection, and follow-up. The change of hematologic parameters (white blood cell count, platelet count and hemoglobin level) and the side effects were recorded and evaluated on months 1, 3 and 6 as well as annually after PBSC donation. During follow-up, long-term side effects and life quality were investigated by questionnaires. The results showed that the total MNC count of bone marrow and PBSC from related donors was 6.70 (4.11 - 12.23) x 10⁸/kg, and the total CD34(+) cell count was 3.40 (1.61 - 13.57) x 10⁶/kg; the total MNC count of PBSC from unrelated donors was 6.69 (3.35 - 11.48) x 10⁸/kg, and the total CD34(+) cell count was 3.50 (1.15 - 11.60) x 10⁶/kg. The main side effect of mobilization was bone pain, reported in 47.0% of the related donors and in 43.7% of unrelated ones, the main side effect of collection was paresthesia, reported in 25.0% of the related donors and in 29.6% of unrelated ones, there was no significant difference on side effects between related and unrelated donors during mobilization and collection of hematopoietic stem cells, all donors could endure these side effects, and no donor discontinued G-CSF administration because of side effects. After collection, the hemoglobin level of related donors was lower than that of unrelated donors [(125.8 ± 20.2) g/L vs (143.2 ± 20.1) g/L] (p < 0.05) because of bone marrow and peripheral blood collection, and the platelet count of unrelated donors were lower than that of related donors [(126.2 ± 57.2) x 10⁹/L vs (162.4 ± 72.9) x 10⁹/L] (p < 0.05) because of more than two times of collection. There was no significant difference on hematologic parameters between two groups during long-term follow-up, and the majority of the donors reported were in good or very good health. It is concluded that the donation proved from related and unrelated donors is safe to mobilize hematopoietic stem cells for allogeneic transplantation. Long-term monitoring of healthy PBSC donors remains important to guarantee the safety standards of bone marrow and peripheral blood stem cell mobilization and collection, including comprehensive medical examination before mobilization and collection, careful manipulation during collection, long term follow up after collection and so on.

The application of predeposit autotransfusion in hematopoietic stem cell donors

[Short-Term Effects of Hemogram in Healthy Donors after Peripheral Blood Stem Cell Collection].

The Characteristics of Blood Transfusion and Analysis of Preoperative Factors Associated with Intraoperative Blood Transfusion in Congenital Heart Surgery: a Case–control Study

[Effect of Different Hemapheresis Procedures on Components of Hematopoietic Stem Cells Collected from Healthy Donors].

Investigation on related factors of CD 34+ cells in peripheral blood mobilization effect by G-SCF stimulation

Predictive factors for the development of anemia after hematopoietic stem cell donation

Clinical Observation on Hemogram Variation of Allogeneic Donors from Chinese Population for Peripheral Hematopoietic Stem Cell Collection.

[Effect of donor bone marrow transfusion on renal allograft function in kidney transplant patients].

Application of Component Apheresis in Pre-deposited Autotransfusion.

Effects of peripheral blood CD34 + cells count on the collection timing and results of peripheral blood stem cells

Clinical Observation of Factors in the Efficacy of Blood Component Transfusion in Patients Following Hematopoietic Stem Cell Transplantation

Exploration on the Effect of Predeposit Autotransfusion on Bone Marrow Hematopoiesis after Femoral Shaft Fracture.

Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors]

Analysis on expansion potentials and pre-clinical safeties of hematopoietic stem cells from human umbilical cord blood.

Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings

Personalized autologous stem cell harvesting improves patient collection outcomes

Retrospective Study of Autotransfusion in Cardiopulmonary Bypass

ABO Incompatible Donor Allogeneic Peripheral Blood Stem Cell Collection

Research Progress on Clinical Significance of Peripheral Blood CD34 + Cells Count in Autologous Stem Cell Mobilization and Collection

Donor‐type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant

Investigation of the effect of collecting peripheral blood stem cell/progenitor cell with Amicus blood cell separator